CERVICURA

DNA vaccines; preventive vaccines; pharmaceutical preparations for gene therapy; drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of head and neck cancer; injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; pharmaceutical preparations for the treatment of cervical cancer; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the treatment of cervical pre-cancer; vaccines; therapeutic vaccines; pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; dermatological pharmaceutical products; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections; pharmaceutical preparations for anticancer immunotherapy; anti-cancer preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia